CLINICAL_TRIALS
trial_result
· 2022-05-04
Clinical Trial Update: A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy [Phase 2]
Summary
Phase 2 trial evaluating pharmacodynamic activity of E2730 in adults with photosensitive epilepsy was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Photosensitive Epilepsy | Phase 2 | Status: TERMINATED | Results posted: 2022-05-04